首页> 美国卫生研究院文献>BMC Cancer >Second and third look laparoscopy in pT4 colon cancer patients for early detection of peritoneal metastases; the COLOPEC 2 randomized multicentre trial
【2h】

Second and third look laparoscopy in pT4 colon cancer patients for early detection of peritoneal metastases; the COLOPEC 2 randomized multicentre trial

机译:pT4结肠癌患者的第二次和第三次腹腔镜检查可早期发现腹膜转移; COLOPEC 2随机多中心试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundApproximately 20–30% of patients with pT4 colon cancer develop metachronous peritoneal metastases (PM). Due to restricted accuracy of imaging modalities and absence of early symptoms, PM are often detected at a stage in which only a quarter of patients are eligible for curative intent treatment. Preliminary findings of the COLOPEC trial () revealed that PM were already detected during surgical re-exploration within two months after primary resection in 9% of patients with pT4 colon cancer. Therefore, second look diagnostic laparoscopy (DLS) to detect PM at a subclinical stage may be considered an essential component of early follow-up in these patients, although this needs confirmation in a larger patient cohort. Furthermore, a third look DLS after a negative second look DLS might be beneficial for detection of PM occurring at a later stage.
机译:背景大约20%至30%的pT4结肠癌患者发生异时性腹膜转移(PM)。由于成像方式的准确性受到限制且没有早期症状,因此常常在只有四分之一的患者有资格进行根治性治疗的阶段检测到PM。 COLOPEC试验的初步结果()显示,在9%的pT4结肠癌患者的一次手术后两个月的手术再探查过程中已经检测到PM。因此,尽管亚临床诊断腹腔镜检查(DLS)在亚临床阶段检测PM可能被认为是这些患者早期随访的重要组成部分,尽管这需要在更大的患者队列中进行确认。此外,在负第二外观DLS之后的第三外观DLS可能对检测后期发生的PM有益。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号